Stock EMMLD OKYO PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart OKYO Pharma Limited

Equities

EMMLD

GG00BMFG5F62

Delayed Nasdaq
Other stock markets
 14:56:51 20/06/2024 BST 		5-day change 1st Jan Change
1.25 USD -2.34% Intraday chart for OKYO Pharma Limited -8.09% -29.38%
03-22 H.C. Wainwright Adjusts Price Target on OKYO Pharma to $7 From $6, Maintains Buy Rating MT
03-22 OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
OKYO PHARMA LIMITED Stock OKYO Pharma Limited
 42.54M - - - - -
CSL LIMITED Stock CSL Limited
 94.45B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 38.9B
BIOGEN INC. Stock Biogen Inc.
 32.56B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 15.98B
INCYTE CORPORATION Stock Incyte Corporation
 13.82B
  1. Stock Market
  2. Equities
  3. EMMLD Stock
  4. Charts OKYO Pharma Limited
  5. Sector Chart